Gain Therapeutics Inc (GANX) stock news · $53.0M cap
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
This GANX news page leads with what Gain Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for GANX yet. We will not pad this page with generic market recap.
Latest reported GANX revenue for 2023-09-30 was $55.2K. Net income was -$4.7M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. GANX currently screens at market cap $53.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GANX stock page; for the tape open the quote page.
GANX stock news FAQ
What are GANX's latest revenue and net income?
Latest cached Gain Therapeutics Inc (GANX) revenue for Sep 30, 2023 was $55.2K. Net income was -$4.7M. Statements: https://lician.com/financials/ganx
How did GANX revenue change from the prior cached period?
Cached Gain Therapeutics Inc (GANX) revenue was unchanged from $55.2K (Jun 30, 2023) to $55.2K (Sep 30, 2023). Statements: https://lician.com/financials/ganx
What is GANX's market cap?
Gain Therapeutics Inc (GANX) market cap is $53.0M on the latest cached fundamentals snapshot.
What kind of company is GANX?
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Where is GANX stock news listed?
Cached stock news for Gain Therapeutics Inc (GANX) is listed at https://lician.com/news/ganx. Filings: https://lician.com/sec/ganx
Not investment advice.